In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan ...

While much of the pharma sector has been retreating from the development of new antimicrobials in recent decades, GSK has ...

The drug is in the same class as Eli Lilly’s tirzepatide-based Mounjaro and Zepbound products, respectively for type 2 ...

The accelerated approval comes a few weeks after Breyanzi (lisocabtagene maraleucel or liso-cel) became the first CAR-T to be ...

The day will continue with breakout sessions on drug pricing and patient engagement, a cell and gene therapy panel packed ...

The House has backed an updated version of the bill that includes a later deadline of 31st January 2032 for US companies to ...

AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen ...

New startup Uniquity Bio arrived on the scene today with $300 million in funding from Blackstone Life Sciences and a clinical ...

New startup Uniquity Bio arrived on the scene today with $300 million in funding from Blackstone Life Sciences and a clinical ...

However, the growing prominence of AI chatbots in healthcare also raises some real concerns about patient trust, ...

Eisai and Biogen have filed a rolling biologics license application in the US for a subcutaneous formulation of Alzheimer’s ...

The US FDA has approved a human papillomavirus (HPV) self-sampling solution developed by Roche that allows patients to ...